(MedPage Today) — CHICAGO — Patients who fasted during chemotherapy for ovarian cancer had significantly longer progression-free survival (PFS) compared with patients who ate a normal diet, a small randomized study from Italy showed.
Fasting…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
